Depression trials in Poland

In Poland 22 Also abroad 666

22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Where
Belchatow, Białystok, Bydgoszcz, Gdansk, Leszno, Poznan, Pruszkow, Tuszyn, Wroclaw
Age
18 years to 65 years
People
360 worldwide
Run by
Seaport Therapeutics
See details and how to joinNCT07065240 · EU 2025-521240-37-00
Phase 2Enrolling by invitation
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
Where
Belchatow, Bialystok, Białystok, Bydgoszcz, Gdansk, Leszno, Poznan, Pruszkow, Tuszyn
Age
18 years to 66 years
People
360 worldwide
Run by
Seaport Therapeutics
See details and how to joinNCT07161700 · EU 2025-522347-18-00
Phase 2Not yet taking people in Poland
A Study of Brenipatide in Participants With Major Depressive Disorder
Where
Bialystok, Bydgoszcz, Gdansk, Lodz, Lublin, Olkusz, Rybnik, Suchy Las, Warsaw
Age
18 years to 75 years
People
330 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07928245 · EU 2026-527689-65-00
Phase 3Taking people
A research study to compare the antidepressant ability and safety of Samyr® tablets versus placebo tablets as an adjunct to additional antidepressant treatment in patients with major depressive disorder (MDD)
Where
Gdansk, Katowice, Poznan, Suchy Las
Age
18 years and over
People
868 worldwide
Run by
Mylan Inc.
See details and how to join2024-513019-29-00 · EU 2024-513019-29-00
Phase 3Taking people
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Where
Bialystok, Bielsko-Biala, Gdansk, Krakow, Poznan, Szczecin, Wroclaw, Zabrze
Age
18 years to 75 years
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07412756 · EU 2025-522308-25-00
Phase 3Taking people
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Where
Bydgoszcz, Gdansk, Gorlice, Grudziądz, Katowice, Leszno, Poznan, Warsaw
Age
18 years to 74 years
People
752 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06559306 · EU 2023-509070-36-00
Phase 3Taking people
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Where
Bialystok, Bielsko-Biała, Bydgoszcz, Cracow, Gdansk, Leszno, Lodz, Olkusz, Poznań, Wroclaw, Zabrze
Age
18 years to 75 years
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07775300 · EU 2025-522310-24-00
Phase 3Taking people
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Where
Bydgoszcz, Gdansk, Warsaw
Age
18 years to 85 years
People
330 worldwide
Run by
Cybin IRL Limited
See details and how to joinNCT06793397 · EU 2024-519270-40-00
Phase 3Taking people
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Where
Belchatow, Białystok, Bia?ystok, Bydgoszcz, Gdansk, Grudziądz, Katowice, Torun, Warsaw
Age
18 years and over
People
850 worldwide
Run by
Neurocrine Biosciences
See details and how to joinNCT06966401 · EU 2024-519423-24-00
Phase 3Taking people
A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Where
Białystok, Bydgoszcz, Gdansk, Warsaw
Age
18 years and over
People
550 worldwide
Run by
Neurocrine Biosciences
See details and how to joinNCT07196501 · EU 2025-520541-72-00
Phase 2Taking people
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Where
Gdansk, Katowice, Poznan
Age
18 years to 75 years
People
300 worldwide
Run by
Draig Therapeutics Ltd
See details and how to joinNCT07300969
Phase 3Enrolling by invitation
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Where
Bialystok, Bydgoszcz, Gdansk, Warsaw
Age
18 years to 85 years
People
468 worldwide
Run by
Cybin IRL Limited
See details and how to joinNCT06605105 · EU 2024-516805-22-00
Phase 3Taking people
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Where
Białystok, Bia?ystok, Bydgoszcz, Gdansk, Katowice, Suchy Las, Torun, Tuszyn, Warsaw
Age
18 years to 65 years
People
500 worldwide
Run by
Vanda Pharmaceuticals
See details and how to joinNCT06830044 · EU 2024-520333-68-00
Phase 2Taking people
DT-101 in Adults with Major Depressive Disorder
Where
Gdansk, Katowice, Poznan, Suchy Las
Age
18 years and over
People
175 worldwide
Run by
Draig Therapeutics Limited
See details and how to join2025-522784-15-00 · EU 2025-522784-15-00
Phase 4Not yet taking people in Poland
Evaluation of the efficacy of Trazodone in improving emotional blunting symptoms in Patients with Major Depressive Disorder
Where
Gdansk, Katowice
Age
18 years to 64 years
People
120 worldwide
Run by
Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Enunciabile Anche Angelini Pharma Italia S.p.A. Angelini Pharma S.p.A. A.C.R.A.F. S.p.A. Acraf S.p.A. Angelini S.p.A. aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
See details and how to join2025-523267-38-00 · EU 2025-523267-38-00
Phase 4Taking people
TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children
Where
Poznan
Age
12 years and over
People
180
Run by
Poznan University of Medical Sciences
See details and how to joinNCT07478796
No phaseTaking people
Real-world Clinical Response to Trazodone in Italy, Poland, and Romania
Where
Lodz
Age
55 years and over
People
120
Run by
Aziende Chimiche Riunite Angelini Francesco S.p.A
See details and how to joinNCT07377682
Phase 3Taking people
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Where
Belchatow, Białystok, Bia?ystok, Gdansk, Grudziądz, Katowice, Torun
Age
18 years and over
People
200 worldwide
Run by
Neurocrine Biosciences
See details and how to joinNCT06786624 · EU 2024-519418-29-00
Phase 3Taking people
The use of sildenafil in patients with univentricular heart after Fontan operation - a pilot SINFON-POL study.
Where
Warsaw
Age
18 years and over
People
60
Run by
National Institute Of Cardiology
See details and how to join2023-503913-31-01 · EU 2023-503913-31-01
No phaseEnrolling by invitation
Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
Where
Gdansk
Age
18 years to 90 years
People
140
Run by
Medical University of Gdansk
See details and how to joinNCT05565352
No phaseTaking people
Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression
Where
Krakow
Age
18 years to 65 years
People
90
Run by
Jakub Antczak
See details and how to joinNCT06363981
No phaseTaking people
Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression
Where
Warsaw
Age
18 years to 65 years
People
90
Run by
Jakub Antczak
See details and how to joinNCT06371352